Recombinant Gloeobacter violaceus NADPH-dependent 7-cyano-7-deazaguanine reductase (queF)

Shipped with Ice Packs
In Stock

Description

Introduction

Gloeobacter violaceus is a cyanobacterium notable for lacking thylakoids and possessing unique structural features in its photosynthetic protein complexes . Carotenoid biosynthesis in G. violaceus is light-dependent, which compensates for photooxidation, particularly of β-carotene .

This document focuses on the enzyme Recombinant Gloeobacter violaceus NADPH-dependent 7-cyano-7-deazaguanine reductase, commonly referred to as queF.

QueF Enzyme Overview

QueF is an enzyme involved in the biosynthesis of queuosine, a modified nucleoside found in the tRNA of bacteria and eukaryotes. Queuosine is located in the first position of the anticodon of tRNAs specific for aspartic acid, asparagine, histidine, and tyrosine. The enzyme queF catalyzes a crucial step in the queuosine biosynthetic pathway. Specifically, queF, utilizing NADPH as a cofactor, reduces 7-cyano-7-deazaguanine to 7-deazaguanine.

Carotenoid Biosynthesis

Carotenoid analysis of Gloeobacter violaceus identifies β-carotene as the major carotenoid and echinenone as a minor component . This composition is unique, with cellular amounts lower than in other unicellular cyanobacteria . The genome analysis of G. violaceus has identified gene candidates homologous to carotenogenic genes from other organisms .

In vitro activity of RuBisCO from G. violaceus

G. violaceus RuBisCO's large subunit (RbcL) at 2 mM RuBP concentration showed a specific activity of 0.005 lmol of PGA min-1 mg-1 of protein . The activity of the protein increased with RuBP concentration, with a KMK_M RuBP value of 0.1917 mM and a VmaxV_{\text{max}} value of 0.0002 min-1 . The turnover number of the protein was 0.0029 s-1 .

When renatured G. violaceus RbcL was reconstituted with RbcS in the presence of RbcX, the activity of the protein increased fourfold . The specific activity observed after complementation was 0.0196 lmol min-1 mg-1 . The KMK_M RuBP of the protein for the LSu?SSu (RbcL?RbcS) complex also improved to 0.102 mM, and the VmaxV_{\text{max}} of the protein complex increased to 0.011 min-1 . The turnover number of the protein complex was 0.016 s-1 .

ParameterRbcLRbcL?RbcS Complex
Specific Activity (lmol min-1 mg-1)0.0050.0196
KMK_M RuBP (mM)0.19170.102
VmaxV_{\text{max}} (min-1)0.00020.011
Turnover Number (s-1)0.00290.016

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a reference.
Shelf Life
Shelf life depends on several factors: storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If a specific tag type is required, please inform us; we will prioritize its development.
Synonyms
queF; gll3593; NADPH-dependent 7-cyano-7-deazaguanine reductase; EC 1.7.1.13; 7-cyano-7-carbaguanine reductase; NADPH-dependent nitrile oxidoreductase; PreQ(0) reductase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-137
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Gloeobacter violaceus (strain PCC 7421)
Target Names
queF
Target Protein Sequence
MSDLPVAPTP AEPVKYGERA IEAGQLITFP NPRPGRDYDI HITLPEFTCK CPFSGYPDFA TIYLTYVPHE KVVELKALKL YVNSFRDRYI SHEEVVHVVL DDFVAAADPL RVQIKGDFNP RGNVHMVVEA RHTRPGT
Uniprot No.

Target Background

Function
Catalyzes the NADPH-dependent reduction of 7-cyano-7-deazaguanine (preQ0) to 7-aminomethyl-7-deazaguanine (preQ1).
Database Links

KEGG: gvi:gll3593

STRING: 251221.gll3593

Protein Families
GTP cyclohydrolase I family, QueF type 1 subfamily
Subcellular Location
Cytoplasm.

Q&A

What is the biological function of queF in nucleoside modification pathways?

QueF catalyzes a biochemically unique reaction in the queuosine biosynthetic pathway – the NADPH-dependent reduction of 7-cyano-7-deazaguanine (preQ0) to 7-aminomethyl-7-deazaguanine (preQ1) . This reaction represents the only known example of biological nitrile reduction . The end product of this pathway, queuosine, is a modified nucleoside found in bacterial and eukaryotic tRNA .

The queuosine modification pathway is particularly significant because:

  • PreQ0 serves as a shared precursor in pathways leading to the insertion of 7-deazapurine derivatives in both tRNA and DNA

  • It illustrates the plasticity of modification pathways between RNA and DNA

  • The presence of 7-deazapurine in DNA is proposed to function as a protection mechanism against endonucleases

In the context of Gloeobacter violaceus, queF is part of an evolutionarily ancient biosynthetic pathway, as this organism represents one of the most primitive cyanobacterial lineages .

What is the structural organization of queF and how does it relate to its catalytic function?

QueF belongs to the tunneling-fold (T-fold) structural superfamily . Crystal structure analysis of QueF from Vibrio cholerae at 1.53 Å resolution reveals that:

  • The protein monomer consists of two ferredoxin-like domains with additional structural embellishments

  • The functional unit forms as a dimer of dimers (tetramer) in crystal structures, though solution data suggests a dimer-monomer equilibrium in solution

  • Each monomer contains a binding site for preQ0 substrate in a cavity formed near the dimer interface

The T-fold architecture is significant because:

  • QueF is homologous to type I GTP cyclohydrolases (like FolE) in primary structure

  • Despite this homology, queF catalyzes a mechanistically unrelated reaction

  • QueF represents the only known example of amidinotransferase chemistry and tRNA binding function in the T-fold structural superfamily

QueF proteins can be classified into two T-fold subfamilies:

  • Unimodular QueF: forms a homodecamer with catalysis occurring at intersubunit interfaces

  • Bimodular QueF: forms a homodimer with catalysis occurring at the intrasubunit interface between two T-fold modules

What methodologies are optimal for expressing and purifying recombinant queF?

Successful expression and purification of recombinant queF typically follows these methodological approaches:

Expression systems:

  • E. coli expression systems have been successfully used for queF from multiple species

  • Expression vectors with appropriate fusion tags (His-tag) facilitate purification

  • Induction conditions should be optimized for temperature, IPTG concentration, and duration

Purification protocol:

  • Cell lysis under native conditions (sonication or pressure-based disruption)

  • Initial capture using affinity chromatography (typically Ni-NTA for His-tagged constructs)

  • Further purification via ion exchange chromatography

  • Final polishing step using size-exclusion chromatography

  • Quality assessment by SDS-PAGE (target purity ≥85%)

Activity preservation:

  • Purification buffers should maintain pH ~7.5, as this represents optimal pH for enzymatic activity

  • Include moderate ionic strength buffers without metal chelators

  • Consider addition of reducing agents to protect active site cysteine residues

  • Storage in glycerol-containing buffers at -80°C maintains long-term stability

How are the kinetic parameters of queF determined and what are the reference values?

The kinetic characterization of queF enzymes involves several complementary approaches:

Methodological approaches:

  • Spectrophotometric assays: Monitor NADPH consumption at 340 nm

  • HPLC-based assays: Quantify preQ0 consumption and preQ1 formation

  • Coupled enzyme assays: For more sensitive detection in complex systems

Steady-state kinetic analysis:
For Bacillus subtilis queF, the following parameters have been determined :

ParameterValueUnits
kcat0.66 ± 0.04min⁻¹
KM (preQ0)0.237 ± 0.045μM
KM (NADPH)19.2 ± 1.1μM

Experimental conditions for optimal activity:

  • pH: 7.5

  • Buffer: Moderate ionic strength

  • Temperature: 25-37°C (organism-dependent)

  • No dependency on metal ions for catalytic activity

For accurate determination of kinetic parameters, researchers should:

  • Ensure enzyme concentration is in the linear range of activity

  • Maintain substrate concentrations spanning 0.2-5× KM values

  • Include appropriate controls for background NADPH oxidation

  • Perform measurements at least in triplicate

What is the proposed catalytic mechanism of queF and what evidence supports it?

The nitrile reduction catalyzed by queF proceeds through a unique mechanism involving covalent catalysis. The proposed mechanism is supported by multiple lines of evidence:

Key mechanistic steps:

  • Nucleophilic attack by an active site cysteine (Cys55 in B. subtilis) on the nitrile carbon of preQ0

  • Formation of a thioimide intermediate

  • NADPH-dependent reduction of the thioimide (requires 2 NADPH molecules per reaction cycle)

  • Release of the preQ1 product

Supporting evidence:

  • Spectroscopic evidence: Formation of an α,β-unsaturated thioimide intermediate produces a characteristic absorption band at 376 nm

  • Site-directed mutagenesis: Substitution of Cys55 with Ala or Ser results in complete loss of catalytic activity and eliminates the 376 nm absorption band

  • Chemical modification studies: Preincubation with iodoacetamide inactivates the enzyme, while substrate (preQ0) protects against inactivation

  • Structural analysis: Crystal structures position the cysteine residue in proximity to the substrate binding site

The mechanism represents the first known example of biological nitrile reduction and establishes a new paradigm for NADPH-dependent reactions.

How do researchers distinguish between different queF homologs in experimental systems?

Researchers can differentiate between queF homologs using several complementary approaches:

Sequence-based identification:

  • Presence of the QueF-specific motif involved in NADPH binding distinguishes queF from related FolE proteins

  • Absence of zinc-binding residues characteristic of FolE further confirms queF identity

  • Phylogenetic analysis can classify queF proteins as unimodular or bimodular variants

Structural characterization:

  • Quaternary structure determination via size-exclusion chromatography and native PAGE

  • Crystallographic analysis to confirm T-fold architecture

  • Mapping of active site residues through structural alignment

Functional assays:

  • Substrate specificity testing with preQ0

  • NADPH-dependence confirmation

  • pH optima and buffer requirements

  • Steady-state kinetic parameters comparison

For Gloeobacter violaceus queF specifically:

  • Gene identification: gll3593

  • Alternative annotation: "hypothetical protein gll3593"

  • Confirmation of activity with recombinant protein purified to ≥85% purity

What challenges exist in crystallizing queF for structural studies?

Crystallizing queF for high-resolution structural studies presents several technical challenges:

Common crystallization obstacles:

  • Protein stability during concentration and crystallization

  • Heterogeneity in oligomeric states (e.g., dimer-monomer equilibrium observed in solution)

  • Flexibility of loop regions (residues 138-168 in V. cholerae queF)

  • Substrate/cofactor binding effects on conformational states

Successful crystallization strategies:

  • Co-crystallization approaches: Crystals of V. cholerae queF were obtained through co-crystallization with GTP, though only guanine, phosphate, and pyrophosphate were observed in the final structure

  • Optimization of crystal growth conditions: Various crystallization parameters must be systematically tested:

    • Protein concentration

    • Precipitant type and concentration

    • pH and buffer composition

    • Temperature

    • Additive screening

Data collection considerations:
For Pyrobaculum calidifontis QueF-Like (QueF-L), which shares homology with queF, the following parameters yielded high-quality diffraction data :

Crystal ParameterValue
Space groupC2, P21
Resolution1.94-2.74 Å
Unit cell dimensionsa,b,c = 215.28, 126.73, 65.05 Å (C2)
a,b,c = 62.21, 124.99, 74.40 Å (P21)
Monomers per asymmetric unit15 (C2), 10 (P21)

How does queF from Gloeobacter violaceus compare to queF from other organisms?

QueF from Gloeobacter violaceus provides unique insights due to this organism's evolutionary status as one of the most primitive cyanobacteria:

Evolutionary context:

  • Gloeobacter violaceus lacks thylakoid membranes, with photosynthesis occurring in cytoplasmic membranes

  • It branched off from the main cyanobacterial lineage at an early evolutionary stage

  • The genome of G. violaceus (4.66 Mbp) is smaller than the closely related species G. kilaueensis (4.72 Mbp) and G. morelensis (4.92 Mbp)

Comparative sequence analysis:

  • QueF from G. violaceus shares approximately 63% sequence identity with the experimentally characterized queF from E. coli

  • The gene encoding queF in G. violaceus is annotated as gll3593

  • Comparison with other queF proteins can identify conserved active site residues and structural motifs

Functional implications:

  • The presence of queF in this evolutionarily ancient organism suggests the early emergence of queuosine biosynthesis

  • Study of G. violaceus queF may provide insights into the evolution of nitrile reduction chemistry

  • The primordial nature of this cyanobacterium makes it valuable for understanding the origins of modified nucleosides in RNA and DNA

What quasi-experimental designs (QEDs) are most appropriate for studying queF function in biological systems?

When randomized controlled trials are not feasible for studying queF function, researchers can employ various quasi-experimental designs:

Non-equivalent groups design:

  • Compare organisms or cell lines with naturally occurring differences in queF expression

  • Analyze phenotypic differences while controlling for confounding variables

  • Example application: Comparing tRNA modification profiles between wild-type and queF-deficient bacterial strains

Regression discontinuity design:

  • Utilize natural thresholds in queF expression or activity

  • Compare outcomes just above and below this threshold

  • Example application: Studying bacteria with queF expression levels above or below a certain threshold under stress conditions

Interrupted time series:

  • Monitor outcomes before and after introduction of a queF inhibitor

  • Analyze the pattern of change following intervention

  • Example application: Tracking changes in tRNA modification patterns after chemical inhibition of queF

Methodological considerations:

  • Clearly define the counterfactual (what would have happened without intervention)

  • Select appropriate control groups that match intervention groups on key characteristics

  • Collect baseline data before intervention

  • Employ statistical techniques to control for confounding variables

  • Consider threats to internal validity (selection bias, history effects, maturation)

What role does queF play in the broader context of tRNA and DNA modification pathways?

QueF functions within an interconnected network of modification pathways affecting both tRNA and DNA:

Integration in queuosine biosynthesis:

  • QueF catalyzes the conversion of preQ0 to preQ1, a key step in queuosine biosynthesis

  • This pathway requires sequential action of multiple enzymes:

    • GTP cyclohydrolase I (FolE) for initial GTP processing

    • Several intermediate steps producing preQ0

    • QueF-catalyzed reduction to preQ1

    • tRNA-guanine transglycosylase (bTGT) incorporation of preQ1 into tRNA

    • Additional enzymes for final queuosine formation

Cross-talk between RNA and DNA modification:

  • PreQ0 serves as a shared precursor for modifications in both tRNA and DNA

  • The presence of 7-deazapurine derivatives in DNA is proposed to protect against endonucleases

  • These modification pathways demonstrate remarkable evolutionary plasticity

Salvage pathways:

  • Many organisms with bTGT homologs lack enzymes for preQ0 synthesis and/or queF

  • PreQ0/preQ1 salvage involves specific transporters:

    • ECF family transporters (QueT and QrtT)

    • COG1738/YhhQ family serves as preQ0-specific transporters in E. coli

  • Some bacteria like Chlamydia trachomatis may directly salvage queuine

Implications for research:

  • QueF represents a potential target for antimicrobial development

  • Understanding these pathways may provide insights into bacterial adaptation

  • The unique nitrile reduction chemistry of queF may inspire new biotechnological applications

How can researchers effectively analyze the structural dynamics of queF during catalysis?

Understanding the structural dynamics of queF during catalysis requires sophisticated experimental and computational approaches:

Experimental techniques:

  • Time-resolved crystallography: Capture structural snapshots during the reaction using techniques like:

    • Trigger-freeze approaches

    • Serial crystallography at X-ray free-electron lasers

    • Temperature-jump methods

  • Spectroscopic methods:

    • UV-visible spectroscopy to monitor formation of the thioimide intermediate at 376 nm

    • NMR for detecting structural changes and intermediate formation

    • Fluorescence resonance energy transfer (FRET) with strategically placed fluorophores

  • Chemical trapping of intermediates:

    • Use of substrate analogs that form stable complexes

    • Rapid quenching techniques to capture transient species

    • Site-directed mutagenesis to stabilize reaction intermediates

Computational approaches:

  • Molecular dynamics (MD) simulations:

    • Probe protein flexibility and substrate binding

    • Sample conformational changes during catalysis

    • Identify water networks and proton transfer pathways

  • Quantum mechanics/molecular mechanics (QM/MM) calculations:

    • Model electronic structure changes during catalysis

    • Calculate energy barriers for reaction steps

    • Predict effects of mutations on reaction mechanism

  • Markov state modeling:

    • Integrate experimental data with computational predictions

    • Identify metastable states during the catalytic cycle

    • Determine rate-limiting steps in the reaction

The combination of these approaches can reveal how protein dynamics contribute to the exceptional chemistry of nitrile reduction by queF.

What are the most effective methods for studying the physiological impact of queF mutations or deletion?

Researchers investigating the physiological consequences of queF alterations can employ several methodological approaches:

Genetic manipulation strategies:

  • Gene knockout/knockdown:

    • CRISPR-Cas9 for precise gene editing

    • Transposon mutagenesis for random disruption

    • Antisense RNA for modulating expression levels

  • Site-directed mutagenesis:

    • Target conserved residues (e.g., Cys55 in B. subtilis)

    • Create catalytically inactive variants

    • Introduce mutations that affect substrate binding but not catalysis

  • Complementation studies:

    • Reintroduce wild-type or mutant queF

    • Use inducible promoters to control expression timing and levels

    • Cross-species complementation to assess functional conservation

Phenotypic analysis:

  • tRNA modification profiling:

    • Liquid chromatography-mass spectrometry (LC-MS)

    • High-resolution techniques to quantify modified nucleosides

    • Pulse-chase experiments to measure turnover rates

  • Growth and stress response assays:

    • Growth curve analysis under various conditions

    • Competition assays between wild-type and mutant strains

    • Stress response to oxidative, temperature, or nutrient challenges

  • Translational fidelity assessment:

    • Reporter systems for measuring mistranslation rates

    • Ribosome profiling to detect translational pausing

    • Proteomics to identify systemic effects on protein synthesis

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.